Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -10.2120.685.2614.2023.15

What is the latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS is -10.21 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-10.21
Mar202420.68
Mar20235.26
Mar202214.20
Mar202123.15

How is EBIT Growth of LINCOLN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -10.21
Negative
Mar2024 20.68
293.16
Mar2023 5.26
-62.96
Mar2022 14.2
-38.66
Mar2021 23.15 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹955.1 Cr -2.6% -6.8% -39.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,590.0 Cr -2% -6.1% -6.7% Stock Analytics
DIVIS LABORATORIES ₹170,577.0 Cr -0.8% -0.8% 8.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,301.0 Cr 0% 2.7% 11% Stock Analytics
CIPLA ₹120,471.0 Cr -0.6% -2.6% 0.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,660.0 Cr -1.3% 0.6% -6.4% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-2.6%

-6.8%

-39.6%

SENSEX

-1%

-1.2%

7.9%


You may also like the below Video Courses